期刊文献+

P-gp、TopoⅡ和GST-π在大肠癌中的表达及其意义 被引量:5

Expression and significance of P-gp,Topo Ⅱ and GST-π in colorectal carcinoma
暂未订购
导出
摘要 目的 探讨P gp、TopoⅡ和GST π在大肠癌的表达情况及其临床意义。方法 运用免疫组织化学技术 (SP法 )检测P gp、TopoⅡ和GST π在 6 9例大肠癌中的表达情况。 结果  (1) 6 9例大肠癌中 ,P gp表达者 6 0 87% ,TopoⅡ表达者 5 9 42 % ,GST π表达者 79 71% ,P gp和GST π共同表达者 5 2 17%。 (2 )P gp在高分化腺癌中高表达 ,在低分化腺癌低表达 (P =0 0 2 6 )。 (3)单因素分析表明 ,P gp表达与大肠癌患者的生存期和不良预后有关。Cox回归分析表明 ,P gp表达、P gp和GST π共同表达与患者的生存率有关 ,TopoⅡ表达对患者有保护趋势。结论 实验表明 ,P gp、TopoⅡ和GST π等多因素联合作用是大肠癌多药耐药性的主要作用机制。对大肠癌患者进行此三项指标的测定 。 Objective To elucidate the relationship of the expression of P-gp,TopoⅡ α and GST-π in colorectal carcinomas and their clinical significance.Methods The expression of P-gp,TopoⅡ α and GST-π in 69 cases of colorectal carcinomas were investigated using immunohistochemical SP method.Results (1)Of the 69 cases of colorectal carcinomas,62.32% were positive for P-gp,59.42% for TopoⅡα,and 79.71% for GST-π.The co-expression of P-gp and GST-π was 52.17%.(2)A significant relationship was found between P-gp expression and pathological grade,that is,the cases with high expression showed good differentiation and those with low expression showed poor differentiation (p=0.026).(3)The analysis of single factor revealed a significant relationship between P-gp expression and the prognosis of patients with positive P-gp expression had a shorter average survival time.The correlation with prognosis was analyzed by Cox proportion hazard model.It showed that P-gp expression and co-expression of P-gp and GST-π were independently associated with patient survival length (P<0.05),while TopoⅡα may play a protective role.Conclusions The experiment shows that the combinative effect of P-gp,TopoⅡα and GST-π may be the chief mechanism of multidrug resistance of the patients with colorectal carcinoma and P-gp plays the most important role.The assay of P-gp,TopoⅡα and GST-π in patients with colorectal carcinoma is important and has instructive significance to estimate prognosis and work out a chemotherapy plan.
出处 《江苏医药》 CAS CSCD 北大核心 2002年第1期8-11,共4页 Jiangsu Medical Journal
关键词 多药耐药 大肠癌 免疫组织化学 预后 Multidrug resistance Colorectal carcinoma Prognosis Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献2

共引文献9

同被引文献42

  • 1应杰儿,钟海均,冯海洋.FOLFOX4方案治疗晚期大肠癌的临床观察[J].肿瘤防治杂志,2005,12(18):1423-1424. 被引量:28
  • 2许小飞,曹兴建,刘雅洁,张晓鹃.环氧合酶-2在食管癌中表达及与血管生成关系[J].南通大学学报(医学版),2007,27(2):83-85. 被引量:9
  • 3BARNES N, HAYWOOD P, FLINT P,et al. Survivin expression in in situ and invasive breast cancer relates of COX-2 expression and DCIS recurrence [ J ]. Br J Cancer,2006,94 ( 2 ) :253-258.
  • 4HIROSE M, HOSOI E, HAMANO S, et al. Muhidrug resistance in hematological malignancy[ J ]. J Med Invest, 2003, 50 (34) : 126-135.
  • 5SIMSEK T, OZBILIM G, GULKESEN H, et al. Drug resistance in epithelial ovarian cancer: P-glycoprotein and glutation S-transferase. Can they play an important role in detecting response to platinum-based chemotherapy as a first-line therapy [ J ]. Eur J Gynaecol Oncol, 2001, 22(6) : 436438.
  • 6TAN M, LAN K H, YAO J, et al. Selective inhibition of erbB2- overexpressing breast cancer in vivo by a novel TAT-based erbB2- targeting signal transducers and activators of transcription 3-blocking peptide[J]. Cancer Res, 2006, 66(7) :3764-3772.
  • 7LEE A, PARK WC, YIM HW, ctal. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast [ J ]. Jpn J Clin Oncol, 2007, 37(9) :708-714.
  • 8CORZO C, BELLOSILLO B, COROMINAS J M,et al. Does polysomy of chromosome 17 have a role in ERBB2 and topoisomerase Ⅱ alpha expression7 Gene, mRNA and protein expression: a comprehensive analysis [ J ]. Tumour Biol, 2007, 28 (4) :221-228.
  • 9GRUSHKO T A, FILIACI V L, MUNDT A J, et al. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 2008, 108( 1 ) :3-9.
  • 10Starrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells [ J ]. Biochemistry(Mosc) , 2000, 65 ( 1 ) :95-106.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部